934841-22-2 Usage
Uses
Used in Pharmaceutical Industry:
Carbamic acid, N-[(1S,3S)-3-[4-methoxy-3-(3-methoxypropoxy)benzoyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-dimethylethyl ester is used as a key ingredient in the development of various drugs, particularly for its antiviral and antiproliferative properties. Its unique structure allows it to target specific biological pathways, making it a valuable component in medicinal formulations.
Used in Organic Synthesis:
In the field of organic synthesis, this carbamic acid derivative serves as an intermediate in the synthesis of more complex organic compounds. Its versatile chemical structure enables it to participate in a range of reactions, facilitating the creation of new molecules with potential applications in various industries.
Used in Chemical Research:
Carbamic acid, N-[(1S,3S)-3-[4-methoxy-3-(3-methoxypropoxy)benzoyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-dimethylethyl ester is also utilized in chemical research to explore its reactivity, stability, and potential interactions with other molecules. This research contributes to the understanding of its properties and possible applications in different chemical processes.
It is crucial to handle and use Carbamic acid, N-[(1S,3S)-3-[4-methoxy-3-(3-methoxypropoxy)benzoyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-dimethylethyl ester with care due to its potential hazardous properties, ensuring safety in laboratories and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 934841-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,8,4 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 934841-22:
(8*9)+(7*3)+(6*4)+(5*8)+(4*4)+(3*1)+(2*2)+(1*2)=182
182 % 10 = 2
So 934841-22-2 is a valid CAS Registry Number.
934841-22-2Relevant academic research and scientific papers
NEW METHODS
-
Page/Page column 66-67, (2008/12/04)
The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula (I) or a salt thereof, wherein R1 as well as Act are as defined in the specification, and processes of manufacturing this compound as well as intermediates in this process.
ORGANIC COMPOUNDS
-
Page/Page column 68-69, (2010/11/27)
The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula II, or a salt thereof, and a compound of formula Vl or a salt thereof, wherein R3 and R4 as well as Act are as defined in the specification, and processes of manufacturing these. Additionally transformation of compounds (Vl) with metallo organic compounds (VII) give rise to the new compounds (VMI) which are direct precursors for the preparation of Aliskiren.